Stock data
Enveric Biosciences, Inc. (ENVB)
Enveric Biosciences, Inc. (ENVB) reported net income of -US$8.77M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$8.77M | -US$8.77M | — |
| 2024 | — | — | -US$9.63M | -US$9.57M | — |
| 2023 | — | — | -US$16.45M | -US$17.29M | — |
| 2022 | — | — | -US$27.42M | -US$18.47M | — |
| 2021 | — | — | -US$64.62M | -US$48.98M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$3.03M | — |
| 2026-03-31 | — | -US$1.63M | — |
| 2025-12-31 | — | -US$2.19M | — |
| 2025-09-30 | — | -US$1.87M | — |
| 2025-06-30 | — | -US$2.52M | — |
| 2025-03-31 | — | -US$2.18M | — |
| 2024-12-31 | — | -US$3.15M | — |
| 2024-09-30 | — | -US$2.08M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.